Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia

Leukemia

Volumn 11, Issue 2, 1997, Pages 212-220

  Xi, Z F ^a   Russell, M ^b   Woodward, S ^b   Thompson, F ^b   Wagner, L ^b   Taetle, R ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

APL; EVI 1; Zn finger

Indexed keywords

RETINOIC ACID; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTINUOUS CULTURE; DNA SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PATHOGENESIS; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0031058632     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400547     Document Type: Article

References (15)

1. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988; 54: 831-840.
2. Bordereaux D, Fichelson S, Sola B, Tambourin PE, Gisselbrecht S. Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol 1987; 61: 4043-4045.
3. Latchman DS. Eukaryotic transcription factors. Biochem J 1990; 270: 281-289.
4. Rhodes D, Klug A. Zinc fingers: they play a key part in regulating the activity of genes in many species, from yeast to humans. Fewer than 10 years ago no one knew they existed. Sci Am 1993; 268: 56-65.
5. t-28 CTCATCTTC. Oncogene 1995; 10: 1961-1967.
6. Perkins AS, Kim JH. Zinc fingers 1-7 of EVI1 fail to bind to the GATA motif by itself but require the core site GACAAGATA for binding. J Biol Chem 1996; 271: 1104-1110.
7. Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea JM, Gisselbrecht S. Evi-1 expression in leukemic patients with rearrangements of the 3q25-28 chromosomal region. Leukemia 1992; 6: 93-99.
8. Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Ihle JN. Activation of evi-1 gene expression in human acute myelogenous leukemias by rearrangements spanning 300-400 kb on chromosome 3q26. Proc Natl Acad Sci USA 1992; 89: 3937-3941.
9. Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 1994; 84: 1243-1248.
10. Russell M, Thompson F, Spier C, Taetle R. Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis. Leukemia 1993; 7: 1654-1657.
11. Oval J, Jones OW, Montoya M, Taetle R. Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26). Blood 1990; 76: 1369-1374.
12. Oval J, Smedsrud M, Taetle R. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1. Leukemia 1992; 6: 446-451.
13. Perkins AS, Mercer JA, Jenkins NA, Copeland NG. Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development. Development 1991; 111: 479-487.
14. Morishita K, Parganas E, Matsugi T, Ihle JN. Expression of the evi1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor. Mol Cell Biol 1992; 12: 183-189.
15. Kreider BL, Orkin SH, Ihle JN. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the EVI-1 myeloid-transforming gene. Proc Natl Acad Sci USA 1993; 90: 6454-6458.